Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes

Overview of attention for article published in OncoTargets and therapy, March 2016

Altmetric Badge

Mentioned by

reddit: 1 Redditor

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 12 Mendeley

Summary Reddit Dimensions citations

So far, Dimensions has found 14 publications that cite this research output.

14

The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.

QT-Interval Prolongation, Torsades de Pointes, and Heart Failure With EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Systematic Review

Article in Clinical Lung Cancer (February 2024)

Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: A meta-analysis

Article in European Journal of Clinical Pharmacology (February 2024)

Complete pathologic response to neoadjuvant icotinib in stage IIIA EGFR-mutant lung adenosquamous carcinoma: A case report

Article in Medicine (January 2024)